Occluflex - Prospective randomized multi-center controlled clinical investigation comparing PFO outcomes of the Occlutech Figulla Flex II PFO Occluder to standard of care PFO occlusion.

Disease Sites:

Not Available

Staging:

Phase II/III

Age Group:

Adults

Therapies:

Not Available

Drugs:

Not Available

Principal Investigator(s):

Piana, Robert

Scope:

International

Participating Institutions:

Vanderbilt University

Open Date:

02-24-2022

Trial Type:

Treatment

Protocol ID:

CRE-INT0005

National Clinical Trial ID:

NCT05069558

View Internal Documents

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available